Streetbeat News

Analyst Ratings

YEXT

Yext shares rose following a strong Q2 earnings report and positive FY25 revenue guidance. Needham upgraded the stock to Buy with an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:16 pm

CELH

Stifel analyst Mark Astrachan maintains a Buy rating on Celsius Holdings (NASDAQ:CELH) but lowers the price target from $61 to $51.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:14 pm

BMRN

Truist Securities has maintained a Buy rating on Biomarin Pharmaceutical but lowered the price target from $140 to $118.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:12 pm

BWMX

Small Cap Consumer Research analyst Eric Beder has reiterated a Buy rating for Betterware de Mexico SAPI (NYSE:BWMX) and maintained a price target of $22.5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:12 pm

ROKU

Wells Fargo analyst Steven Cahall has upgraded Roku from Underweight to Equal-Weight and increased the price target from $50 to $72.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:11 pm

BZH

Wedbush analyst Jay McCanless has upgraded Beazer Homes USA (NYSE:BZH) from Neutral to Outperform and increased the price target from $41 to $45.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:09 pm

JWN

Barclays analyst Paul Kearney has upgraded Nordstrom (NYSE:JWN) from Underweight to Equal-Weight and increased the price target from $18 to $23.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:09 pm

WLK

Piper Sandler analyst Charles Neivert maintains an Overweight rating on Westlake (NYSE:WLK) but lowers the price target from $180 to $170.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:08 pm

CELH

Piper Sandler analyst Michael Lavery maintains an Overweight rating on Celsius Holdings (NASDAQ:CELH) but lowers the price target from $65 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:07 pm

XPEV

JP Morgan analyst Nick Lai has upgraded XPeng (NYSE:XPEV) from Neutral to Overweight and increased the price target from $8 to $11.5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 12:07 pm